Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.4M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
17K
-
Shares change
-
0
-
Total reported value, excl. options
-
$24K
-
Price
-
$1.41
Significant Holders of P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) as of Q4 2023
1 filings reported holding PIII - P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share as of Q4 2023.
P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17K shares
of 12.4M outstanding shares and own 0.14% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (5.44M shares), JANUS HENDERSON GROUP PLC (3.78M shares), BlackRock Inc. (2.54M shares), Alyeska Investment Group, L.P. (1.96M shares), VANGUARD GROUP INC (1.56M shares), EMFO, LLC (1.01M shares), GEODE CAPITAL MANAGEMENT, LLC (846K shares), STATE STREET CORP (670K shares), MILLENNIUM MANAGEMENT LLC (500K shares), and HRT FINANCIAL LP (418K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.